Mendelspod Podcast
Episodes
A Point-of-Care CBC Test Based on a Few Drops of Blood—Is This the Real Thing? with Danny Levner, Sight Diagnostics
25 Oct 2018
Contributed by Lukas
Time is health. Take certain blood cancers, for instance. When a patient is seen in a doctor’s office, they are then sent to a central lab for tes...
It’s a Gold Rush in Single Cell Genomics, Says Joachim Schultze, U of Bonn
15 Oct 2018
Contributed by Lukas
The title says it all here. Herr Professor Schultze directs a major facility that he calls a single cell genomics platform. They have most of the si...
A Market Solution for Biospecimen Quality Standards with Matt McLoughlin, Scientist.com
02 Oct 2018
Contributed by Lukas
We ran a series this summer highlighting one of the major issues in biomedical research: that the collection, storage, and procurement of biospecimen ...
September 2018 with Nathan and Laura: Studying the Same Genes and the Matt Fender Story
28 Sep 2018
Contributed by Lukas
And here we were thinking it was a slow month!We have two big stories today: first this philosophy of biology question about whether it’s a bad th...
Single Cell Sequencing Tailor Made for Nephrology, Says Vivek Bhalla, Stanford
20 Sep 2018
Contributed by Lukas
Vivek Bhalla is used to the question, what’s a nephrologist? When we admitted we’d never had one on the program, he made his own admission, sayin...
It’s the Social Factors, Stupid! Lisa Suennen on Healthcare, Her Career, Digital Health Investing, and . . . Just Being Herself
13 Sep 2018
Contributed by Lukas
She's been a highly sought after venture funder and knowledge broker in the field of digital health. STAT News wrote that upwards of 1,500 pitches cr...
Concerned About DTC Test Quality? Ask Two Questions, Says Daryl Pritchard, PMC
05 Sep 2018
Contributed by Lukas
We like talking to the folks at the Personalized Medicine Coalition (PMC). They have many stakeholders and multifaceted speakers on a wide range of t...
August 2018 Review with Nathan and Laura: The polygenic month
31 Aug 2018
Contributed by Lukas
It’s our first show back after the summer break, and nothing has got us all buzzing about genomics again like a polygenic risk score. It even has L...
An International Perspective on How to Improve Biobanking with Kirstin Goldring
21 Aug 2018
Contributed by Lukas
For the next episode in our summer series on human tissue sample quality and biobanking, we turn to a veteran biobanker in the U.K. who managed severa...
A Seqster Preview with Founder Ardy Arianpour
16 Aug 2018
Contributed by Lukas
As long as we’ve been doing clinical genetics, the goal has been to marry up the genetic data with phenotypic data in the electronic medical records...
Detective Stories from the Genomic War Room with Ramesh Hariharan
26 Jul 2018
Contributed by Lukas
A book like this only comes around once in a while—one never knows from which corner. This time it was written by the CTO of a next gen sequencing ...
Should Biobanking Come Under CLIA? Shannon McCall, Duke
17 Jul 2018
Contributed by Lukas
When former President Obama’s team released the paperwork for what’s become the All of Us Research Program, in the part about biobanking, the word...
Pharma Stepping Up, Footing the Bill for Genetic Testing & Counseling: Jordanna Mora, Alnylam
12 Jun 2018
Contributed by Lukas
It seems to be human nature to value and pay up to hundreds of thousands of dollars for a little white pill that we can drop on the floor--and granted...
Are We Asking Too Much of Genomics in Cancer Research? Tony Letai, Dana Farber
07 Jun 2018
Contributed by Lukas
It’s a question we’ve asked on the program before. Are we over relying on the genomics route getting us to biomedical research paradise? Should ...
I Won’t Rest Until We Have Quality Standards in Place for Biospecimens: Carolyn Compton, ASU
05 Jun 2018
Contributed by Lukas
She’s a force of nature, and she’s back on Mendelspod. A decade ago, Carolyn Compton was hired by the NCI to solve a problem that has plagued the...
May 2018 with Nathan and Laura: The Free Exome, California Database, and Mosaicism
01 Jun 2018
Contributed by Lukas
Nathan Pearson and Laura Hercher are back for a look over a busy month of headlines.May took us into the era of the free genome as Geisinger planted t...
Has Diagnostic Testing Plateaued? Alka Chaubey, Greenwood Genetic Center
24 May 2018
Contributed by Lukas
If you’ve been in the field of genetic testing then you know about the Greenwood Genetic Center. With an address on Mendel Circle in Greenwood, Sou...
A New Way for DTC? Nathan Pearson, Root Deep Insight
17 May 2018
Contributed by Lukas
You know him, but do you know what he does for a day job?Over the past two years, Nathan Pearson has dazzled us with his broad knowledge of the genomi...
Genetic Testing in the Age of Trump: Hank Greely, Stanford
10 May 2018
Contributed by Lukas
"In a world turned upside down, this is an area where I don’t think he’s had much effect. I don’t think he knows how to spell “DNA.”"So be...
Genetic Testing is Dead, Long Live Genetic Testing: Sean George of Invitae
03 May 2018
Contributed by Lukas
A few years ago they were the new kid on the block, and now they are a leader of mainstream genetic testing. Last year their revenue and profit were ...
April 2018 with Nathan and Laura: Golden State Killer and the Cancer Prediction Space
01 May 2018
Contributed by Lukas
After decades on the loose, it’s cool the cops finally caught him. But is it cool how they caught him?Nathan Pearson and Laura Hercher are back for...
Liquid Biopsy for Infectious Disease with Mickey Kertesz, Karius
24 Apr 2018
Contributed by Lukas
Sequencing goes to the world of infectious disease. This is a public episode. If you'd like to discuss this with other subscribers or get access to bo...
Nanopore Sequencing and the Future of Cancer Research with Chia-Lin Wei, JAX
18 Apr 2018
Contributed by Lukas
We can all recognize that PacBio has laid down the railroad tracks in the frontier of long read sequencing. What many are asking is just how close on...
A New Method for Long Reads: Hanlee Ji of Stanford on Cancer Genomics Tech 2018
10 Apr 2018
Contributed by Lukas
Hanlee Ji is the Senior Associate Director of the Stanford Genome Technology Center as well as an oncologist at Stanford. He’s also a clinical gene...
March 2018 in Genomics with Nathan & Laura: DTC BRCA and Revisiting All of Us
01 Apr 2018
Contributed by Lukas
23andMe steals the headlines yet again.“If somebody is worried about breast cancer susceptibility in their family, they should certainly not be usin...
With More Tools in the Box, Lon Cardon Says We’re in a New Age of Drug Development
21 Mar 2018
Contributed by Lukas
“I think the field has just really come to life over the last five or seven years. We’ve got all this sequence data. We’ve got the population ...
Personalized Medicine in the Trump Era with Edward Abrahams
15 Mar 2018
Contributed by Lukas
The Personalized Medicine Coalition advocates for a wide group of constituents, including scientists, health care providers, entrepreneurs, payers, an...
Eric Schadt and Sema4 Try the Consumer Model with Newborn Screening Panel
06 Mar 2018
Contributed by Lukas
"We like to refer to it as consumer initiated, but physician supervised,” says Eric Schadt today when asked if his new test is direct-to-consumer.Er...
February 2018 in Genomics with Nathan & Laura: 23andMe Goes for the Gold, Trump Year One
01 Mar 2018
Contributed by Lukas
Booking 26 million viewers, the voice of Warren buffet, the endorsements of Olympians Joey Cheek and Tara Lipinski—this company was going for the go...
State of Sequencing 2018 with Keith Robison, Omics! Omics! Blogger
20 Feb 2018
Contributed by Lukas
Sequencing geeks are fresh off the trail from AGBT, and it’s time for our annual look at the sequencing tools space. This year we sit down with the...
Direct RNA-Seq Project Shows Nanopore Sequencing Can Reveal New Insights into Basic Biology: Winston Timp, JHU
06 Feb 2018
Contributed by Lukas
Nanopore sequencing has arrived. Passing test after test this past year--including one we discuss today--this technology which was being hyped decade...
January 2018 Review Show with Nathan and Laura: CRISPR vs The Immune System, Biotech Math, and MinION's Big Test
01 Feb 2018
Contributed by Lukas
Some stocks are up on news of big biotech mergers, but others are down on hearing of the latest difficulties of gene therapy. One thing’s for sure—...
Going Beyond the Liver with RNAi: Chris Anzalone of Arrowhead Pharma
23 Jan 2018
Contributed by Lukas
Fifteen years ago, folks in the industry were buzzing about RNAi the way they talk about CRISPR today. Then things went quiet for the technology, at ...
Vice Chancellor Keith Yamamoto on UCSF’s Role in Medicine Today
15 Jan 2018
Contributed by Lukas
A major chapter in the history of medicine has been written by UC San Francisco. They are writing the next for precision medicine. This is a public e...
The Global Business of Reproductive Genetic Testing with Gary Harton, Igenomix
11 Jan 2018
Contributed by Lukas
Reproductive testing is one of the hottest fields in which genetics is going mainstream, a field hurdling us rapidly into the future. It’s an area ...
The State of Genomics 2018 with Nathan, Laura, and Misha
08 Jan 2018
Contributed by Lukas
Our first show of the year is an outlook on genomics for 2018. To do this we’re joined by our regular commentators, Nathan Pearson and Laura Herche...
Sharon Begley of STAT News
19 Dec 2017
Contributed by Lukas
Sharon Begley joins us for our last show of the year to look back over some of the year’s top stories. She’s the senior science writer at STAT Ne...
A New “Middle Way” for Genomics, with Physical Chemist, Yuval Ebenstein
13 Dec 2017
Contributed by Lukas
“I love low tech,” says today’s guest.It’s not your typical catch phrase for 2017. But then today’s guest is not your typical genome scien...
Sara Demy on Biotech CEOs
04 Dec 2017
Contributed by Lukas
Our topic today: biotech leadership. What makes a good biotech CEO? Are there unique issues to biotech and diagnostics that shape and demand a diff...
November 2017 with Nathan and Laura: The Stem Cell Story We’ve All Been Waiting For and a Sea Change for DTC Testing
01 Dec 2017
Contributed by Lukas
It didn’t take long to come up with our lead story for November’s month in review show. Looking at the pictures of the boy in Germany playing soc...
Seattle Startup Takes Precision Oncology to the Next Step: Carla Grandori, CEO, SEngine
16 Nov 2017
Contributed by Lukas
Carla Grandori was for thirty years a cancer researcher most recently at the Fred Hutch in Seattle. She had her personal reasons for working on cance...
Immuno Oncology 2017: Looking Back, Looking Forward with Rachel Laing and Olivier Lesueur
14 Nov 2017
Contributed by Lukas
Immuno oncology is now the dominant topic at Mendelspod. From shows with CEOs presenting new panels of predictive biomarker tests, to the firsts at th...
Huh? 30 Million Americans Have a Rare Disease? Howard Jacob on the State of Clinical Sequencing
09 Nov 2017
Contributed by Lukas
Here’s a title for you. Chief Genomics Officer. Today’s guest is also the VP of Genomic Medicine and a faculty investigator at the HudsonAlpha I...
With their Own Manufacturing Facility, Seattle Children’s Goes Big into CAR-T, Rare Disease
07 Nov 2017
Contributed by Lukas
The past few months have seen the first approvals at the FDA for CAR-T cancer therapies. But trials have been going on for years. And not just by bi...
With Immuno Oncology Comes a New Focus on Rare Cells
01 Nov 2017
Contributed by Lukas
Modena, Italy is the town where one of the world's rarest cars were first developed and built: the Ferrari sports car. It’s also home to one of t...
We've Become Too Single Variant Centric, Says Deanna Church on Genome Analysis
12 Oct 2017
Contributed by Lukas
From 1999 to 2013, Deanna Church was a staff scientist at the NCBI where, for a time, she headed the Genome Reference Consortium. This was the effort...
Clinicians Show High Demand for Single Cell Sequencing, Says Bobby Sebra of Mt. Sinai
05 Oct 2017
Contributed by Lukas
If today's guest were a super hero, he'd be High Resolution Sequencing Man.Bobby Sebra is the Director of Technology Development at the Icahn Institut...
September 2017 with Nathan and Laura: Venter Blunder, RNAi Returns, and Monthly Science Moments
02 Oct 2017
Contributed by Lukas
To honor Laura's pentametric thirst,We write the summary today in verse. Was it a quake that had no epicenter,That silly paper out by J. Craig Vente...
Charting the Dark Matter of Cancer Genomes with Jim Broach
26 Sep 2017
Contributed by Lukas
We’ve heard a lot this year about the search for new structural variants and the hope that scientists will find new causal linkages for diseases suc...
Why Childhood Cancers Need Their Own Gene Panel: Tim Triche
21 Sep 2017
Contributed by Lukas
When we first talked with Tim Triche of LA Children's Hospital, we found out he was a bit of an outlier among cancer researchers. He was an advocate ...
Exploring the Exome and the Future of Genomics with Jay Shendure
13 Sep 2017
Contributed by Lukas
Back in 2009, University of Washington professor, Jay Shendure, wrote a definitive paper offering up a roadmap for exome sequencing. Since then, the c...
August 2017 Review with Nathan and Laura: CAR-T Cashes In, Embryos Edited in US, and the Invitae Incident
01 Sep 2017
Contributed by Lukas
Back from summer vacation, Nathan and Laura are smoking hot as they look back over some exciting headlines.The summer boiled over with plenty to talk ...
The First In-Human Gene Editing Trial in the U.S. - And It’s Not with CRISPR
08 Aug 2017
Contributed by Lukas
The challenge for the first ever in-human gene editing trial, according to today’s guest, is with the delivery to the body.“At the moment, the eas...
Thermo, Pfizer, and Novartis Pull Off a First for NGS in Lung Cancer
03 Aug 2017
Contributed by Lukas
Today we get to bring you a feel good story, one of the major achievements so far in precision oncology. Three large companies—Thermo Fisher, Pfize...
Making Genetic Testing Mainstream Medicine with Sean George, Invitae
01 Aug 2017
Contributed by Lukas
Invitae appointed their co-founder Sean George as CEO earlier this year. He joins us to share his bold vision for the field of genetic testing. This ...
Need Better Standards for Your Clinical Assays? NIST Can Help
27 Jul 2017
Contributed by Lukas
The life science tools space is flourishing. Biomedical research output is at an all time high. Today’s guest says there are over 40,000 papers pu...
Turning on Your DNA with Justin Kao, Helix
25 Jul 2017
Contributed by Lukas
They’re getting a lot of buzz this week. We’re pleased to have Justin Kao, a co-founder of Helix on the program today for the first time. This is...
Will This New Nano Technology Be the Microarray of Genomic Structural Variation? Barrett Bready, Nabsys
20 Jul 2017
Contributed by Lukas
Barrett Bready is back on the program. He’s the CEO of Nabsys, a company with some new technology for genome mapping.Originally Nabsys had been wor...
George Church on What Comes After CRISPR
13 Jul 2017
Contributed by Lukas
George Church joins us today. He’s the Robert Winthrop Professor of . . . . well, he’s George Church. And he confirms that, yes, a movie called ...
Is CRISPR Controversy Science or Spin? June 2017 Review with Nathan and Laura
30 Jun 2017
Contributed by Lukas
It’s the end of the month--and the half year mark--so we open up today's monthly discussion with Nathan and Laura to include some of the headlines w...
We Need a Google Maps for Metagenomics, Says Rob Knight, UCSD
27 Jun 2017
Contributed by Lukas
When will we see the results of microbiome research in our every day lives? And what will that look like?Rob Knight joins us for the first time today...
Move Over PDL1: New Test Combo Adds RNAseq to Better Track Immune Escape
22 Jun 2017
Contributed by Lukas
Reports from ASCO, the nation’s biggest cancer conference, this year again were full of stunning stories about the success of older and new immuno t...
The Last Major Disease To Be Studied? Ron Davis of Stanford Thinks So
15 Jun 2017
Contributed by Lukas
Let’s say you’re a biomedical researcher looking for a place to make your mark. You find out that there is still a major disease that affects mo...
On Bioinformatics Data Sharing and Collaboration: Andrew Carroll, DNAnexus
08 Jun 2017
Contributed by Lukas
What does it take to collaborate in genomics?A platform, for one thing. Over the past few years bioinformaticians have been speculating about a domin...
Grail Merger, Genomic Autopsies, Overtreatment Alarm, and Controversy at Ancestry.com: May 2017 Review with Nathan and Laura
01 Jun 2017
Contributed by Lukas
Is Grail already merging? Genomic autopsies? Does the House's new healthcare bill turn mere genetic risk into pre-conditions? Nathan and Laura are b...
Is Population Medicine Failing Us? Michel Accad
25 May 2017
Contributed by Lukas
Is health the same thing for an individual as it is for a population? This question goes to the foundation of how we practice medicine today and that ...
Deep Omics Profiler, Mike Snyder, Now Turns to Wearables
18 May 2017
Contributed by Lukas
Mike Snyder is well known in the genomics community for his iPOP (integrated personal omics profiling) study. Profiling himself with hundreds of thous...
Over $1 Billion Invested this Past Year: Synthetic Biology in 2017 with John Cumbers
11 May 2017
Contributed by Lukas
What does it take to make it in synthetic biology in 2017? This is a public episode. If you'd like to discuss this with other subscribers or get acces...
Green Light for DTC, Blood Mammograms, and Ancient DNA: April 2017 with Nathan and Laura
01 May 2017
Contributed by Lukas
For genomics nerds, April 2017 will be remembered as the date when the FDA adopted a more open policy towards 23andMe and direct-to-consumer (DTC) gen...
With 50 Million Users, Is Academia.edu Speeding Up Science?
18 Apr 2017
Contributed by Lukas
Today we follow up with Richard Price, the founder and CEO of the most popular social sharing site for the academic sector, Academia.edu. When we t...
How to Improve Lab Tests in the Absence of FDA Regulation?
13 Apr 2017
Contributed by Lukas
Rubbing shoulders at molecular medicine conferences these days one senses a sigh of relief when you talk about laboratory developed tests (LDTs). Wit...
Known for Medical Devices, 116 Yr Old BD Makes a Bold Move in Genomics
05 Apr 2017
Contributed by Lukas
Talk to someone who attended this year’s AGBT, and you’ll know the big buzz was about single cell genomics. One of the exciting new platforms cam...
Proposed NIH Cuts, Undermining GINA, and Game Changing Drugs: March 2017 with Nathan and Laura
31 Mar 2017
Contributed by Lukas
The largest cut to NIH budget ever, rolling back genetic non-discriminatory law—the bad news continues to roll from Washington. But there was great...
Art in the Lab (Falling in Love with Bacteria)
28 Mar 2017
Contributed by Lukas
Today’s guest makes time to create beauty in the lab. Memo Berkmen is a bacterial artist along with being a staff scientist at New England Bio Labs....
Flint Whistleblower Says Today's Science Is to Blame for Its Own Lack of Public Trust
16 Mar 2017
Contributed by Lukas
Marc Edwards is telling a different story than the one most of us have been reading and hearing lately. But then he’s used to it.Marc was the engin...
The Story of Geisinger and Doing Genomic Medicine at the Right Pace
08 Mar 2017
Contributed by Lukas
Mike Murray and the crew over at Geisinger are making the implementation of genomic medicine look down right easy.In today’s interview, Mike explain...
In-Situ Sequencing, CRISPR Patents, and Racist Milk Drinkers: February 2017 with Nathan and Laura
01 Mar 2017
Contributed by Lukas
Commentators Nathan Pearson and Laura Hercher join us to look back on February’s genomics headlines.Beginning this time with science, Nathan says we...
New Pocket Size Nanopore Device Could Revolutionize Diagnostic and Other Testing
20 Feb 2017
Contributed by Lukas
First of all, watch the video below.A Santa Cruz company is now previewing a nanopore device that could be a major disruptor in molecular testing. Th...
By Changing a Basic Lab Step, Acoustic Liquid Transfer Having a Broad Impact
13 Feb 2017
Contributed by Lukas
Freeman Dyson famously said, “the great advances in science usually result from new tools rather than from new doctrine.”Today we talk with Mark F...
Many Biologists Today Don’t Have Enough Computer Science to Use the Databases
09 Feb 2017
Contributed by Lukas
Moray Campbell was for all intents and purposes an accomplished and successful cancer biologist at the renowned Roswell Park Cancer Center. Then one ...
Cardiologists Love Genomics: Euan Ashley, Stanford
07 Feb 2017
Contributed by Lukas
Euan Ashley is one of the big names in genomic medicine that has been missing from our guest list. We’re happy to correct that today.In 2010, he le...
Scientists vs Trump: January 2017 with Nathan and Laura
02 Feb 2017
Contributed by Lukas
As we look back at January’s headlines with our two regular commentators, Nathan and Laura, the question becomes: How much should we ignore the fir...
Want to Stop Smoking? Start with Epigenetic Biomarker that Tells Doc the Truth
31 Jan 2017
Contributed by Lukas
Why are there no viable psychiatric genetic tests, we ask today’s guest.Rob Philibert is a geneticist and psychiatrist working at the University of ...
When an Exome Test Is Part of the Therapy and Not a Diagnostic: John West on Personalis and Personalized Cancer Vaccines
24 Jan 2017
Contributed by Lukas
Podcast brought to you by: Slone Partners - Providing the leaders that shape the clinical trials space. About six years ago there was a wave of genom...
People Told Us It Was Impossible: UCSC’s Mark Akeson on Nanopore Sequencing
18 Jan 2017
Contributed by Lukas
Mark Akeson has been working on nanopore sequencing at UC Santa Cruz’s biophysics lab for twenty years. Up until the past few years with the launch ...
When Long Reads are Double the Price of Short Reads, Short Reads Are Dead, Says Evan Eichler
12 Jan 2017
Contributed by Lukas
Each year at this time, sequencing tools leader, Illumina, generates another round of sequencing buzz in the industry, this year by announcing the $10...
Genomics in 2016: Nathan and Laura Name Their Top Stories
28 Dec 2016
Contributed by Lukas
From new CRISPR trials in humans to mitochondrial transfer therapy, from the spinout by Illumina of two new genomics health companies to the complete ...
Hank Greely on “The End of Sex" and Other Stuff
22 Dec 2016
Contributed by Lukas
Each year at this time we bring on a guest who is somewhat out of the way of our normal lineup, for example, a science fiction writer or a philosopher...
How to Scale Cancer Genomics, with Marco Marra, UBC
06 Dec 2016
Contributed by Lukas
Back in 2009 at the annual AGBT meeting for sequencing, Marco Marra presented one of the first cases of cancer treatment using whole genome sequencing...
What Does the Election Mean for Genomics? November 2016 with Nathan and Laura
01 Dec 2016
Contributed by Lukas
While everyone is asking what will become of Obamacare, we ask our regular commentators, Nathan Pearson and Laura Hercher, specifically about genomics...
The Saga Continues: Ethan Perlstein, Indie Scientist, Part 3
29 Nov 2016
Contributed by Lukas
Today Ethan Perlstein joins us on the program for a third time. His path as a ‘rogue scientist’ has become a bit of a case study here at Mendelsp...
Biomarker Panel to Predict Type 1 Diabetes
17 Nov 2016
Contributed by Lukas
When we talk precision medicine on Mendelspod, we’re usually talking about oncology. But today we shift our focus to diabetes.Raghu Mirmira is an M...
Can You Name the World’s Largest Single Disease Research Charity?
15 Nov 2016
Contributed by Lukas
Let’s take a break from the US and head over to the UK, home of the world’s largest single disease medical research charity.Cancer Research UK (CR...
Why Diversity Is the Only Path Forward: Sarah Tishkoff on African Genomics
03 Nov 2016
Contributed by Lukas
Are you lactose tolerant? If you’re of Northern European ancestry this is because of a stretch of DNA in a gene enhancer that developed some 9,000 ...
October 2016 with Nathan and Laura
01 Nov 2016
Contributed by Lukas
Today’s show was recorded on Halloween, which now feels so yesterday. Forgive us for some spookiness.What doesn’t feel so yesterday is the launch...
We’re Over Halfway There: Baylor's Richard Gibbs on Clinical Genetics
25 Oct 2016
Contributed by Lukas
There’s a basic assumption in our field today that has been around for some time. We think of medicine as on a direct and even continuum with scie...
With FDA Guidance on LDTs Still Not Out, What Are Labs Doing?
19 Oct 2016
Contributed by Lukas
As we get closer to the election and the end of 2016, the debate over LDT regulation has gone quiet. At this time last year, there was one hearing af...
Reference Genome Making Major Strides in Ethnic Diversity, Says Valerie Schneider, NCBI
11 Oct 2016
Contributed by Lukas
A couple months back, we reported on a study showing that genetic tests for an inherited heart disorder were more likely to come back with false posit...
September 2016 with Nathan and Laura
04 Oct 2016
Contributed by Lukas
There were many headlines this past week heralding the first three parent baby to be born. But in fact, as our commentators point out in today’s lo...
Luke Timmerman on His New Biography of Lee Hood
27 Sep 2016
Contributed by Lukas
There is tons of life science journalism. Our coffee tables and inboxes fill up each week with that quarterly or that daily. We sift through headlin...